Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia

Study identifier:NIS-CSG-CRE-2011/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Registry to Collect Data of Efficacy and Safety Between Rosuvastatin, and Atorvastatin and Simvastatin In Subjects with Type IIa and IIb Hypercholesterolaemia Under Real Clinical Settings

Medical condition

hypercholesterolaemia

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

800

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Aug 2010
Primary Completion Date: 01 Dec 2010
Study Completion Date: 01 Dec 2010

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jan 2015 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria